Aegon

Aegon posted an operating result of €1.7bn (+15%) in the second half of 2025 and a free cash flow of €829m. The company proposed a final dividend of €0.21 and carried out €400m of share buybacks. Despite the figures, the stock fell 4.49% in pre-market trading to $7.45. For 2026–2027 Aegon is targeting annual operating growth of around 5% and plans a further €400m buyback programme as well as a holding cash balance of €1.0bn by the end of 2026. » More on de.investing.com

Aegon reports a 2025 operating result of €1.7bn (+15%) and operating capital generation of €1.3bn, exceeding the €1.2bn target. Free cash flow was €829m, and the proposed final dividend is €0.21 per common share (€0.40 total, +14%). The US business (Transamerica) showed strong growth rates, Financial Assets were reduced to $2.7bn, and capital ratios remained robust. Aegon targets a run-rate annual operating-result growth of around 5% for 2026/27 and annual dividend growth of more than 5%; the stock fell about 5% in premarket trading. » More on de.investing.com

Aegon Ltd. announced at its Capital Markets Day plans to move its legal seat and head office to the United States, with re-domiciliation to be completed by January 1, 2028 and the holding company renamed Transamerica. The company said business units will keep their current brands, it will begin reporting under US GAAP for full-year 2027, and will suspend trading updates in 2026 and 2027 while limiting disclosures to comprehensive half-year reports. Management expects the common stock to remain listed on NYSE and Euronext. Ahead of the CMD, JPMorgan cut its price target to EUR 8 but kept an Overweight rating, while Bank of America maintained a Buy rating with a €7.50 target. » More on finance.yahoo.com